Axsome Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 10/08/2026 | Mar 2026Filed 10/08/2026 | Sep 2025Filed 03/11/2025 | Jun 2025Filed 10/08/2026 | Mar 2025Filed 10/08/2026 | Sep 2024Filed 03/11/2025 | Jun 2024Filed 03/11/2025 | Mar 2024Filed 03/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $218 | $191 | $171 | $150 | $121 | $105 | $87 | $75 | |
| −$51 | −$65 | −$47 | −$48 | −$59 | −$65 | −$79 | −$68 | |
| −$0.99 | −$1.26 | −$0.94 | −$0.97 | −$1.22 | −$1.34 | −$1.67 | −$1.44 | |
| 52 | 51 | 50 | 49 | 49 | 48 | 48 | 47 |
Trend